Clinical Trial Update: Evaluation of Tumor Ablation Effects by Irreversible Electroporation for Patients With Malignant Liver Tumors [NA]

View source ↗

Summary

This update reports completion of a clinical trial evaluating tumor ablation using irreversible electroporation in patients with malignant liver tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Malignant Liver Tumors | NA | Status: COMPLETED